Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Amarin Corp PLC AMRN

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic

Amarin Corporation PLC is a biopharmaceutical company that commercializes and develops therapeutics to improve cardiovascular health.
Price: $1.05 | Change: $0.00 | %Change: 0.00%
Volume: 828,546 | Day High/Low: 1.07/1.00 | 52 Week High/Low: 2.75/0.94


Last Traded: October 15, 2014 07:19 Transaction Volume: 217,972
Open: $1.005 Previous Close: $1.01
Bid: $1.00 Ask: $1.01
Bid Size: 1,400 Ask Size: 6,900
Market Cap: $175.5m Shares Out: 174.6m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts


Krill oil boom is real

Has nothing to do with crude oil or energy but it still has the potential to be just as profitable

Andrew Mickey   June 3, 2011
0 stars

Latest Bullboard Posts

  • Show Me The Money! AMRN Style!

    0 stars

    I have been hearing that there could be a huge IR campaign taking off for AMRN in the near future. I have been holding this stock for a...

    0 stars

  • Valuation

    0 stars

    I don't understand the price discrepancy between Amarin Corp and Pivotal Therapeutics? Pivotal has a similar product (some would say...

    2.5 stars

  • Amarin Corporation (AMRN) short term trade and lon

    0 stars

    Amarin Corporation (AMRN) short term trade and long term option ideas. Short term trade ideas -

    1 star


    0 stars

    Patented Food VS FDA Approval Check this out, I want your thoughts on this ?Pivotal Therapeutics begins Vascazen clinical trialsTicker...

    4 stars


    0 stars

    YOUR THOUGHTS News ReleasePivotal Therapeutics Negotiates Exclusive Rights to Key Diagnosticand Appoints Agent for Clinical TrialsFOR...

    4 stars